People · Operator
Named in public records as an officer, director or promoter · active 2010–2019 · Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cns Therapeutics Inc | — | Pharmaceuticals | Series A | $13.1M | $94.5M | 2010 |
| Wahupta Ventures Inc | — | Other | Pre-Seed | $544K | $12.6M | 2019 |
Richard Penn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard Penn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Nina Kjellson | 1 | 11 |
| John Foster | 1 | 10 |
| Peter McNerney | 1 | 6 |
| Howard Rosen | 1 | 5 |
| Pratik Shah | 1 | 5 |
| Stephen Brohman | 1 | 4 |
| Samuel Anderson | 1 | 4 |
| Andrew LaFrence | 1 | 2 |
| Gerald Wartak | 1 | 1 |
| Roman Rubin | 1 | 1 |
| Keith Green | 1 | 1 |
| Warren Cudney | 1 | 1 |
| Scott Bronson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.